Clinical Trial Update: Avastin Plus Rituximab for Patients With B-Cell Non-Hodgkin's Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating bevacizumab (Avastin) in combination with rituximab for patients with B-cell non-Hodgkin lymphoma has completed with results posted in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• Avastin (bevacizumab)
• Rituxan (rituximab)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2009-08-26